Carapezzi William R JR 4

4 · PFIZER INC · Filed Mar 1, 2022

Form 4

Period: 2022-02-26

Executive Vice President

Transactions

Exercise/Conversion
Common Stock
2022-02-26$25.60/sh+21,193$542,541→ 87,363 total
Tax Payment
Common Stock
2022-02-26$50.64/sh−9,895$501,083→ 72,849 total
Tax Payment
Common Stock
2022-02-28$46.94/sh−1,795$84,257→ 71,054 total
Tax Payment
Common Stock
2022-02-26$47.72/sh−4,619$220,419→ 82,744 total
Exercise/Conversion
Stock Appreciation Rights
2022-02-26−21,193→ 0 total
Exercise: $25.60From: 2022-02-26Exp: 2022-02-26→ Common Stock (21,193 underlying)

Holdings

Footnotes (6)

[F1]The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
[F2]The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
[F3]Price is the closing price of Pfizer common stock on February 25, 2022.
[F4]The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
[F5]Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
[F6]The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the vesting of restricted stock units (including dividend equivalents thereon).

Documents

1 file